Written and maintained by CASRAI Editorial Board
Last updated
A healthcare-associated infection (HAI) is a surveillance category defined by the National Healthcare Safety Network (NHSN), not a clinical diagnosis a physician writes on a chart. NHSN’s operational definition is deliberately narrow: a localized or systemic condition resulting from an adverse reaction to an infectious agent or its toxin, with no evidence the infection was present or incubating at the time of admission to the acute-care setting. Whether a specific case counts as an HAI — and which facility it gets attributed to — is decided by applying a structured set of timing rules, not by clinical impression of when an infection “started.” This page is a reference to that attribution logic across NHSN’s four major device- and procedure-associated HAI types — CLABSI, CAUTI, SSI, and VAE — and the rules that separate a true HAI from a community-onset infection. It is not a substitute for the full site-specific criteria; for those, see CASRAI’s dedicated CLABSI, CAUTI, and VAE guides.
Why “Healthcare-Associated” Is an Attribution Rule, Not a Clinical Judgment
NHSN surveillance exists to produce comparable infection rates across facilities, which means every case has to be attributed using the same rules regardless of what any individual clinician believes about causation. That attribution runs through two linked concepts that apply across every HAI type: the date of event and the infection window period. Understanding these two concepts first makes the type-specific criteria below much easier to read, because CLABSI, CAUTI, SSI, and VAE are all variations on the same underlying logic applied to different anatomical sites and different denominators.
The Date of Event (DOE) and the Infection Window Period (IWP)
The date of event is the date the first element used to satisfy an infection criterion occurs — not necessarily the date a positive culture results, and not the date a clinician documents a diagnosis. For a laboratory-confirmed bloodstream infection under LCBI 1, for example, the DOE is the collection date of the first positive blood specimen; for LCBI 2/3, it’s the date the first qualifying sign, symptom, or specimen occurs, which is not always the same date as the culture itself.
The infection window period is the span of calendar days around the DOE within which all the elements needed to satisfy a given criterion must fall — for most lab-confirmed criteria, this is seven days: the date of the qualifying positive specimen plus the three calendar days before and the three after. Signs, symptoms, and specimens that fall outside that window can’t be combined to build a case, even if they seem clinically related. This window is also what NHSN uses to determine whether a later positive culture represents a new infection event or a continuation of one already counted, via the related Repeat Infection Timeframe (RIT) — generally 14 days from a prior DOE of the same infection type before a new event of that same type can be counted again.
The POA/HAI Boundary: The Day-3 Rule and Its Exceptions
NHSN attributes an infection to the reporting facility based on when its date of event falls relative to the start of the current admission — a rule distinct from, and often confused with, the claims-coding Present on Admission (POA) indicator that Health Information Management assigns for billing purposes. The two “POA” concepts use similar language for different mechanisms; see that guide’s own note on the distinction.
The general NHSN rule, applied consistently across the device-associated modules: counting the day of admission as day 1, an infection whose date of event falls on admission day 1 or day 2 is generally considered present on admission and is not attributed as a new HAI to the current facility — it’s treated as community-onset, or attributed back to a prior facility under the Transfer Rule if the patient arrived from another inpatient setting. An infection whose date of event falls on admission day 3 or later meets the general HAI timing threshold, subject to the specific criterion for that infection type also being satisfied. This is the same >2-calendar-day logic that produces “eligible on central-line day 3” for CLABSI and the equivalent catheter-day threshold for CAUTI — the device-eligibility window and the general HAI attribution window are built from the same day-3 rule.
SSI runs on a different clock entirely. Because a surgical site infection is tied to a procedure, not to the start of an inpatient stay, its surveillance period is measured from the date of the operative procedure, not from admission day — see the SSI row below. The day-3 admission rule does not apply to SSI attribution the way it does to the three device-associated types.
Two further wrinkles worth knowing before treating “day 3” as an absolute rule: the Transfer Rule can attribute an infection to a different facility than the one currently caring for the patient when the patient was transferred from another inpatient location shortly before the DOE, and the Repeat Infection Timeframe described above can mean a positive culture on or after day 3 still doesn’t count as a new HAI event if it falls within 14 days of an already-counted infection of the same type. Both exist for the same reason as the day-3 rule itself: to keep attribution consistent across facilities rather than dependent on where a patient happened to be standing when a culture resulted.
CLABSI, CAUTI, SSI, and VAE Compared
The table below is an orientation map, not a substitute for the full criteria — use it to see how the four types relate before going to the type-specific guide for the one you’re actually adjudicating.
| HAI type | Denominator / eligibility clock | Core criterion structure | Surveillance window |
|---|---|---|---|
| CLABSI (central line-associated bloodstream infection) | Central line in place >2 calendar days (eligible day 3+) | LCBI 1 (recognized pathogen), LCBI 2/any age or LCBI 3/≤1 year (matching commensal + symptom), each with the MBI-LCBI subset and secondary-BSI attribution rule — see the full CLABSI guide | 7-day infection window period around the DOE |
| CAUTI (catheter-associated urinary tract infection) | Indwelling urinary catheter in place >2 calendar days (eligible day 3+) | Symptomatic UTI (SUTI) criteria combining qualifying signs/symptoms with a quantitative urine culture threshold, plus the asymptomatic bacteremic UTI (ABUTI) pathway — see the full CAUTI guide | 7-day infection window period around the DOE |
| SSI (surgical site infection) | Tied to an NHSN operative procedure category, not a device-day count | Three depth categories — superficial incisional, deep incisional, and organ/space — each with its own combination of purulent drainage, positive culture, clinical signs, or physician diagnosis | 30 days after the procedure for most categories; extended to 90 days for procedures involving an implant, per NHSN’s operative-procedure category list |
| VAE (ventilator-associated event) | Mechanical ventilation >2 calendar days (eligible day 3+) | Tiered, objective algorithm — Ventilator-Associated Condition (VAC), then Infection-related VAC (IVAC), then Possible or Probable VAP — built from measurable ventilator-setting changes rather than a clinical VAP diagnosis — see the full VAE guide | Tier-specific windows anchored to the qualifying ventilator-setting change |
The pattern across all four: a defined eligibility clock, a criterion built from objective, checkable elements rather than clinical gestalt, and a bounded time window that keeps the count reproducible across reviewers. SSI is the outlier structurally — it doesn’t share the >2-day admission-linked eligibility clock the other three do — but it shares the same underlying design goal of removing clinical-judgment variability from the count.
True HAI vs. Community-Onset Infection: What Actually Separates Them
In practice, the distinction between a true HAI and a community-onset infection comes down to three checks, applied in order:
- Timing. Does the date of event fall on or after the relevant eligibility threshold (day 3 of admission for the three device-associated types; within the applicable post-procedure window for SSI)? If the DOE falls before that threshold, the infection is generally community-onset or attributable elsewhere under the Transfer Rule, not a new HAI at the current facility.
- Criterion structure. Does the case satisfy the full, specific criterion for that infection type — not just “an infection occurred,” but the exact combination of eligible device/procedure, organism or culture threshold, and sign/symptom elements defined for that type? A clinically obvious infection that doesn’t happen to meet the documented criteria (missing a required blood-culture pair, for instance) does not get counted as an HAI under NHSN surveillance, even though it may be entirely real clinically.
- Secondary attribution. Is the infection actually primary to the site being evaluated, or is it secondary to (i.e., seeded from) an infection at another body site that independently meets its own NHSN criteria? A secondary infection is not counted against the device or procedure it appears adjacent to.
This is also why “hospital-acquired infection” and NHSN’s own “healthcare-associated infection” terminology, while often used interchangeably in casual conversation, both point to the same underlying surveillance-definition concept rather than a bedside diagnosis — and why the count a hospital reports to NHSN can diverge from what frontline clinicians would informally describe as “infections we saw this month.”
Frequently Asked Questions
Is a healthcare-associated infection the same thing as a hospital-acquired infection?
Functionally, yes — both terms describe NHSN’s surveillance concept of an infection not present or incubating at admission that meets a defined site-specific criterion. “Healthcare-associated” is NHSN’s preferred term because surveillance now extends beyond acute-care hospitals to other healthcare settings NHSN tracks.
What is the difference between an HAI and a community-onset infection?
A community-onset infection is one whose date of event falls before the facility-attribution threshold for its type (generally admission day 1 or 2 for the device-associated types), meaning it’s treated as already present rather than acquired during the current stay. An HAI’s date of event falls on or after that threshold and satisfies the type’s full surveillance criterion.
Does every infection a patient develops in the hospital count as an HAI?
No. Only infections that meet a defined NHSN criterion — the right device/procedure eligibility, organism or culture threshold, and sign/symptom combination, within the infection window period — are counted. A clinically real infection that doesn’t meet the documented criteria structure is not an NHSN-reportable HAI, even if it was genuinely acquired during the stay.
Why does SSI use a different surveillance window than CLABSI, CAUTI, and VAE?
Because SSI surveillance is anchored to a discrete event — the operative procedure — rather than to an ongoing device exposure measured in consecutive days. The 30-day (or 90-day, for implant-involving procedure categories) window runs from the procedure date, not from hospital admission.
Is the NHSN “present on admission” concept the same as the claims-coding POA indicator?
No, and conflating them is a common source of confusion. NHSN’s admission-day-3 attribution rule decides whether an infection counts as a new HAI for surveillance purposes; the claims-coding POA indicator (Y/N/U/W) is a separate billing field HIM coders assign per diagnosis code on the UB-04 claim. The two pipelines are built from different rules, run by different teams, and can disagree for the same patient.
This guide summarizes the general structure of NHSN’s HAI attribution logic — date of event, infection window period, the admission-day timing rule, and how CLABSI, CAUTI, SSI, and VAE relate to it — for orientation. NHSN revises its Patient Safety Component Manual annually, typically each January, and the exact day-count thresholds, window lengths, and organism lists are set by that manual. It is not a substitute for the current-year manual chapter for the specific infection type being surveilled, and it is not clinical guidance for individual patient management. For official reporting, always work from the exact current-year CDC NHSN manual chapters and any program-specific reporting instructions.
Related: see the Patient Safety & Infection Prevention hub, the full CLABSI, CAUTI, and VAE guides for the complete site-specific criteria, the Standardized Infection Ratio entry for how these counts become a risk-adjusted rate, the Present on Admission (POA) indicator guide for the parallel claims-coding concept, and the infection preventionist guide for who typically performs this adjudication.
